The U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Atsena Therapeutics' ATSN-201 for the treatment of X-linked retinoschisis (XLRS).
ATSN-201, a...
The European Commission (EC) has approved Otsuka and Lundbeck's Rxulti (brexpiprazole) for the treatment of schizophrenia in adolescents aged 13 years and older. Brexpiprazole...
PSL (Powder Systems Limited), a global leader in solid-liquid separation and drying solutions, has enhanced its CakeStand™ vacuum tray dryer, featuring modular options tailored...